Vanguard Group Inc Capricor Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CAPR
# of Institutions
143Shares Held
12.4MCall Options Held
4.99MPut Options Held
5.52M-
Black Rock Inc. New York, NY1.63MShares$12 Million0.0% of portfolio
-
State Street Corp Boston, MA1.47MShares$10.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA963KShares$7.12 Million0.0% of portfolio
-
Morgan Stanley New York, NY551KShares$4.07 Million0.0% of portfolio
-
Ubs Group Ag549KShares$4.06 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $180M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...